Cancer drugs

Cancer drugs

Drugs, agents used in the treatment of cancer or conditions related to cancer.

Contributors in Cancer drugs

Cancer drugs

A water-soluble, semi-synthetic derivative of the sesquiterpine lactone artemisinin with anti-malarial, anti-shistosomiasis, antiviral, and potential anti-neoplastic activities. Upon hydrolysis of ...

Aziridinylbenzoquinone RH1

Pharmaceutical; Cancer drugs

A water-soluble, synthetic aziridinylbenzoquinone with potential antineoplastic activity. Bioactivation of aziridinylbenzoquinone RH1 occurs through the two-electron reduction of the quinone to the ...

Aurora kinase inhibitor AS703569

Pharmaceutical; Cancer drugs

A water-soluble, synthetic small molecule with potential antineoplastic activity. Aurora Kinase Inhibitor AS703569 selectively binds to and inhibits aurora kinases (AKs), a family of serine-threonine ...

Allogeneic renal cell carcinoma vaccine MGN1601

Pharmaceutical; Cancer drugs

A whole cell vaccine comprised of irradiated allogeneic renal cell carcinoma (RCC) with potential immunostimulating and antineoplastic activities. Allogeneic renal cell carcinoma vaccine MGN1601 ...

Sargramostim plasmid DNA pancreatic tumour cell vaccine

Pharmaceutical; Cancer drugs

A whole cell vaccine comprised of irradiated allogenic pancreatic tumour cells transfected with a plasmid DNA encoding human sargramostim (GM-CSF). Vaccination results in expression of GM-CSF, which ...

GVAX pancreatic cancer vaccine

Pharmaceutical; Cancer drugs

A whole cell vaccine expressing human granulocyte macrophage-colony stimulating factor (GM-CSF) with potential antineoplastic activity. tumour cells from prostate cancer patients are harvested and ...

Recombinant Saccharomyces cerevisia-CEA(610D) vaccine GI-6207

Pharmaceutical; Cancer drugs

A whole, heat-killed, recombinant Saccharomyces cerevisiae yeast-based vaccine genetically altered to express the carcinoembryonic antigen (CEA) peptide 610D with potential immunostimulating and ...